MaxCyte Inc (MXCT) Ord USD0.01 (DI)
5.00p
(3.14%)
- Add to watchlist
- Create an alert
- This stock can be held in a
5.00p
(3.14%)
5.00p
(3.14%)
159.00p
159.85p
253.00p
£88.23 million
159.00p
150.00p
154.00p
n/a
2.00p (1.24%) Previous:
2.00p
14,073
n/a
750
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2018 | 31/12/2017 |
|---|---|---|
| Revenue ($m) | 16.67 | 13.98 |
| Profit before tax ($m) | (8.87) | (9.92) |
| Adjusted EPS (¢): | (17.00) | (20.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Open an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
Broker recommendations for this stock are not available.
-
Sunday share tips: IQE, MaxCyte
26 May 2019 21:53
-
MaxCyte begins dosing second cohort in MCY-M11 clinical trial
8 May 2019 15:58
-
MaxCyte launches new generation of cellular engineering instruments
8 April 2019 08:34
-
Appointment of Joint Corporate Broker
12 June 2019 07:00
-
Save the Date: Capital Markets Day
29 May 2019 07:00
-
Second Price Monitoring Extn
8 May 2019 16:41
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.